Eli Lilly Will Bring Experimental Weight-Loss Pill to India
Eli Lilly plans to launch its experimental oral weight-loss drug orforglipron in India, a senior govt stated on Thursday, providing …
Lilly
Innovent Biologics Challenges Novo and Lilly in China’s GLP-1 Market
Xinermei, launched in July, is the third once-weekly injectable GLP-1 weight administration remedy obtainable in China after Novo Nordisk’s Wegovy …
Eli Lilly Rolls Out Its GLP-1 Strategy Worldwide
Eli Lilly has established itself because the market chief in weight problems medicine in Europe, Asia and the Middle East …